Evidence map›Paper›PMID 41874448›Full record

ArticleCancer discovery2026

Same-Slide Spatial Multiomics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.

Stephanie Pei Tung Yiu, Yuzhou Chang, Yao Yu Yeo, Huaying Qiu, Wenrui Wu, Hendrik A Michel, Xiaojie Jin, Rongting Huang, Shoko Kure, Lindsay Parmelee and 50 more

Abstract read
In one paragraph

Article in Cancer discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

60 authors.

Stephanie Pei Tung YiuCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-1792-247X
Yuzhou ChangCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-4893-1886
Yao Yu YeoCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-7604-2296
Huaying QiuCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0009-0006-7163-2269
Wenrui WuCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-7245-4659
Hendrik A MichelCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-7025-5605
Xiaojie JinPelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, Ohio.ORCID 0009-0000-8586-5860
Rongting HuangDepartment of Pathology, Stanford University, Stanford, California.ORCID 0000-0002-3079-4724
Shoko KureDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-9536-9438
Lindsay ParmeleeCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-2488-3544
Shuli LuoCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0009-0009-5524-7792
Precious CramerCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-1683-6884
Jia Le LeeCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-1600-6437
Yang WangCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0009-0004-6696-5179
Zhangxin ZhaoCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-5589-4510
Jason YeungCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-0118-8079
Nourhan El AhmarDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-9348-204X
Berkay SimsekDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-3631-0903
Razan MohannaDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0009-0008-5313-7904
McKayla Van OrdenTranslational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0009-0008-6831-4707
Wesley S LuTranslational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0009-0007-5584-041X
Kenneth J LivakTranslational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-9105-5856
Shuqiang LiTranslational Immunogenomics Lab, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-9106-6141
Ce GaoDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-9804-261X
Melinda BurgessFrazer Institute, Translational Research Institute, University of Queensland, Brisbane, Australia.ORCID 0009-0004-7520-0311
Colm KeaneFrazer Institute, Translational Research Institute, University of Queensland, Brisbane, Australia.ORCID 0000-0002-9009-9934
Jahanbanoo ShahryariDepartment of Pathology, Stanford University, Stanford, California.ORCID 0009-0003-7630-5804
Leandra G KingsleyDepartment of Pathology, Stanford University, Stanford, California.ORCID 0000-0001-8639-4183
Reem N Al-HumadiDepartment of Pathology, Stanford University, Stanford, California.ORCID 0009-0007-7548-3632
Sahar NasrDepartment of Pathology, Stanford University, Stanford, California.ORCID 0009-0009-8159-0826
Dingani NkosiDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-3946-3016
Sam SadighDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-2557-7415
Philip RockDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York.ORCID 0000-0003-0031-6032
Leonie FrauenfeldDepartment of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.ORCID 0000-0003-4236-5799
Louisa KaufmannDepartment of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.ORCID 0009-0009-4519-1561
Bokai ZhuBroad Institute of Harvard and MIT, Cambridge, Massachusetts.ORCID 0000-0003-3599-9419
Ankit BasakBroad Institute of Harvard and MIT, Cambridge, Massachusetts.ORCID 0000-0001-9240-7147
Nagendra DhanikondaCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0009-0008-0692-6177
Chi Ngai ChanCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-9106-9481
Jordan KrullPelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, Ohio.ORCID 0000-0001-6507-8085
Ye Won ChoDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts.ORCID 0000-0002-1502-2195
Chia-Yu ChenDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts.ORCID 0000-0003-3829-1256
Jonathan BrownDepartment of Mathematics, University of Dayton, Dayton, Ohio.ORCID 0000-0002-2475-833X
Hongbo WangCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-4333-4436
Bo ZhaoDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-8612-5597
Jia-Ying Joey LeeBioinformatics Institute (BII) , Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID 0000-0002-0420-7098
Lit-Hsin LooBioinformatics Institute (BII) , Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID 0000-0001-6303-9840
David M KimDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts.ORCID 0000-0003-4732-4611
Vassiliki A BoussiotisDepartment of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-3963-1518
Baochun ZhangDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-1759-1161
Kevin WeiDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-1821-167X
Alex K ShalekBroad Institute of Harvard and MIT, Cambridge, Massachusetts.ORCID 0000-0001-5670-8778
Brooke E HowittDepartment of Pathology, Stanford University, Stanford, California.ORCID 0000-0002-0309-6680
Sabina SignorettiDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-5000-9105
Christian M SchürchDepartment of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.ORCID 0000-0002-1792-1768
F Stephen HodiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-6825-091X
W Richard BurackDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York.ORCID 0000-0002-5584-584X
Scott J RodigDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-1761-9769
Qin MaPelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-3264-8392
Sizun JiangCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-6149-3142

Funding

Cancer Immune Monitoring and Analysis CenterU24CA224331 · NCI · DANA-FARBER CANCER INST · PI FRANK S HODI, Catherine Ju-Ying Wu · 2017 to 2026
$18.4M
TriState SenNET (Lung and Heart) Tissue Map and Atlas consortiumU54AG075931 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TOREN FINKEL, Melanie Koenigshoff · 2021 to 2026
$14.0M
Molecular Determinants of Response and Resistance to EZH2 and PARP inhibition in Prostate CancerP50CA272390 · NCI · DANA-FARBER CANCER INST · PI MATTHEW L FREEDMAN · 2023 to 2026
$12.0M
The Role of the Y Chromosome in Bladder Tumor Development, Growth And ProgressionP01CA278732 · NCI · CEDARS-SINAI MEDICAL CENTER · PI SUNGYONG YOU · 2023 to 2026
$10.7M
NHP CoreP01AI177687 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Boris Dominik Juelg · 2023 to 2026
$7.4M
Defining Mechanisms of Viral Persistence in Situ at the Single-Cell LevelR01AI149672 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI ESTES, JACOB D · 2020 to 2024
$4.0M
The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunityR01CA238263 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BOUSSIOTIS, VASSILIKI A · 2020 to 2024
$3.1M
Spatial-Temporal Dissection of Stratified Host Tissue Responses to Severe acute respiratory syndrome-related coronaviruses in situ to Understand Intra-host PathogenesisDP2AI171139 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Sizun Jiang · 2022 to 2026
$2.3M
Navigating Pathways of Innate Immunity and Epigenetic Memory in Checkpoint ImmunotherapyR35CA294015 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI VASSILIKI A BOUSSIOTIS · 2025 to 2026
$1.7M
Single cell investigation of co-evolution in cancer cells and host cell immune microenvironmentR50CA251956 · NCI · DANA-FARBER CANCER INST · PI Shuqiang Li · 2020 to 2026
$1.4M
Dissecting Orchestrated Immune Responses to Glioblastoma within the Native Tissue Microenvironment to Improve Treatment OutcomesR01NS139479 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI VASSILIKI A BOUSSIOTIS, Alain Charest · 2025 to 2026
$1.4M
Statistical Power Analysis Framework for Multi-Sample and Cross-Platform Spatial Omics ExperimentsR01GM152585 · NIGMS · OHIO STATE UNIVERSITY · PI Dongjun Chung, Qin Ma · 2024 to 2026
$1.2M
Albert J Ryan FellowshipBlood Cancer Discoveries Grant Program from the Leukemia Lymphoma SocietyBridge ProjectBroad Next Generation AwardCancer Research Institute Immuno-Informatics Postdoctoral Fellowship CRI Award #14614Dye Family FoundationGilead's Research Scholars Program in Hematologic MalignanciesMacMillan Family Foundation Awardee of the Life Sciences Research FoundationNational Institutes of Health (NIH) DP2AI171139National Institutes of Health (NIH) P01AI177687National Institutes of Health (NIH) P01CA278732National Institutes of Health (NIH) P50CA272390National Institutes of Health (NIH) R01AI149672National Institutes of Health (NIH) R01DK138504National Institutes of Health (NIH) R01GM152585National Institutes of Health (NIH) U24CA224331National Institutes of Health (NIH) U54AG075931NCI NIH HHS P01 CA278732NCI NIH HHS P50 CA272390NCI NIH HHS R01 CA238263NCI NIH HHS R35 CA294015NCI NIH HHS R50 CA251956NCI NIH HHS U24 CA224331NIAID NIH HHS DP2 AI171139NIAID NIH HHS P01 AI177687NIAID NIH HHS R01 AI149672NIA NIH HHS U54 AG075931NIDDK NIH HHS R01 DK138504NIGMS NIH HHS R01 GM152585NINDS NIH HHS R01 NS139479Pelotonia Institute of Immuno-Oncology (PIIO)Sanofi iAwardThe Paul G. Allen Frontiers Group
6 · The paper itself

Abstract

Spatial transcriptomics and proteomics have enabled profound insights into tissue organization, yet these technologies remain largely disparate, and emerging same-slide multiomics approaches are limited in plex, spatial resolution, signal retention, and integrative analytics. We introduce IN-situ DEtailed Phenotyping To High-resolution transcriptomics (IN-DEPTH), a streamlined, resource-efficient, commercially compatible workflow using single-cell spatial proteomics-derived imaging to guide transcriptomic capture on the same slide without RNA signal loss. To integrate modalities beyond niche-level mapping, we developed Spectral Graph Cross-Correlation (SGCC), a proteomic-transcriptomic framework resolving spatially coordinated functional state changes across interacting cell populations. Applied to diffuse large B-cell lymphoma (DLBCL), IN-DEPTH and SGCC enabled stepwise discovery from Epstein-Barr virus (EBV)-positive and EBV-negative tumor comparisons with single-cell resolution, revealing coordinated tumor-macrophage-CD4 T-cell remodeling, immunosuppressive C1Q macrophage enrichment, CD4 T-cell dysfunction, and a candidate IL27-STAT3 signaling axis. Collectively, IN-DEPTH enables scalable spatial multiomics to uncover clinically relevant microenvironmental mechanisms and toward robust spatial multimodal AI models. SIGNIFICANCE: IN-DEPTH enables same-slide spatial multiomics across commercial platforms via a protein-first strategy preserving protein epitopes, RNA quality, and tissue integrity. Coupled with SGCC, it resolves coordinated spatial immune remodeling, revealing EBV/LMP1-driven C1Q macrophage polarization and CD4 T-cell dysfunction in DLBCL, with broad applicability to other diseases.

Indexed as

Epstein-Barr Virus InfectionsLymphoma, Large B-Cell, DiffuseTumor MicroenvironmentHerpesvirus 4, HumanHumansMultiomicsProteomicsSpatial Transcriptomics

Identifiers

PMID41874448
PMCPMC13091187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.